IP Library Granted Patent US 8,007,846
Granted Patent B2
US 8,007,846 · App. 11/623,476 · Granted Aug 30, 2011

Mixed amino acid/mineral compounds having improved solubility

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,007,846
App. No.
11/623,476
Granted
Aug 30, 2011
Kind
B2
Abstract

Mixed amino acid/mineral compounds can include at least two amino acids bound to a central mineral atom. The combination of amino acids can be tailored to provide improved solubility, absorption, and/or bioavailability of the mineral. Optionally, organic acids can be bound to the mineral or combined with the chelate in order to further improve solubility, absorption, and/or bioavailability. Compositions including one or more mixed amino acid/mineral compounds can be included in therapeutic regimens for indications in which the mineral may treat and/or prevent a condition or symptom.

Claims (30)

1. A composition comprising:

a metal chelate consisting essentially of:

a iron(II);

a glycine chelated to the iron(II); and

an aspartic acid chelated to the iron(II), wherein the metal chelate has a solubility from about 2.25 M to about 5 M;

a malic acid or salt thereof in an amount of from about 7% to about 8% by weight of the composition to improve solubility of the metal chelate in water;

a succinic acid or salt thereof in an amount of from about 7% to about 10% by weight of the composition to improve intestinal absorption of the metal chelate; and

with the metal chelate in an amount of from about 77% to about 84.5% by weight of the composition.

2. A composition as in claim 1 , wherein the composition comprises:

succinic acid or salt thereof in an amount of about 10% by weight of the composition;

malic acid or salt thereof in an amount of about 7% by weight of the composition; and

the chelate in an amount of about 77% by weight of the composition.

3. A composition as in claim 1 , wherein the composition comprises:

succinic acid or salt thereof in an amount of about 8% by weight of the composition;

malic acid or salt thereof in an amount of about 7% by weight of the composition; and

the chelate in an amount of about 84% by weight of the composition.

4. A composition as in claim 1 , wherein the composition comprises:

succinic acid or salt thereof in an amount of about 7% by weight of the composition;

malic acid or salt thereof in an amount of about 8% by weight of the composition;

glycine in an amount of about 48% by weight of the composition;

aspartic acid in an amount of about 15% by weight of the composition; and

the iron atom in an amount of about 21% by weight of the composition.

5. A composition as in claim 1 , wherein the composition comprises:

fumed silica in an amount of about 0.5% by weight of the composition;

succinic acid or salt thereof in an amount of about 7% by weight of the composition;

malic acid or salt thereof in an amount of about 8% by weight of the composition;

glycine in an amount of about 48% by weight of the composition;

aspartic acid in an amount of about 15% by weight of the composition; and

the iron atom in an amount of about 21% by weight of the composition.

6. A chelate as in claim 1 , wherein the chelate has a solubility of about 2.5 M.

Assignments (9)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jun 29, 2018
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: ALBION LABORATORIES, INC. (FORMERLY ALBION INTERNATIONAL, INC.)
Reel/Frame 046464/0632 →
SECURITY INTEREST Recorded Jun 27, 2018
From: ALBION LABORATORIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 046221/0237 →
MERGER AND CHANGE OF NAME Recorded Jan 30, 2017
From: ALBION INTERNATIONAL, INC.; ALBION HUMAN NUTRITION (DBA); ALBION LABORATORIES, INC.
To: ALBION LABORATORIES, INC.
Reel/Frame 041117/0178 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded May 4, 2016
From: ALBION INTERNATIONAL, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038606/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2009
From: DRUGTECH CORPORATION; ALBION ADVANCED NUTRITION, DBA OF ALBION LABORATORIES, INC.
To: ALBION INTERNATIONAL, INC.
Reel/Frame 022205/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2008
From: ALBION ADVANCED NUTRITION
To: ALBION INTERNATIONAL, INC.
Reel/Frame 021933/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2008
From: THOMPSON, R. CHARLES; ERICSON, CLAYTON; ASHMEAD, STEPHEN
To: ALBION ADVANCED NUTRITION
Reel/Frame 020504/0624 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2008
From: DRUGTECH CORPORATION
To: ALBION INTERNATIONAL
Reel/Frame 020504/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2008
From: BORTZ, JONATHAN
To: DRUGTECH CORPORATION
Reel/Frame 020505/0636 →